XML 36 R25.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Jun. 30, 2022

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Net Income (loss) Per Share

		For the Three Months Ended June 30, (Unaudited)
		2022				2021
Net Income (Loss)		$	(862,382	)		$	(778,455	)
Net income (loss) attributable to common shareholders		$	(862,382	)		$	(778,454	)
Weighted average number of shares of common stock outstanding:
Basic			19,717,919				16,811,513
Diluted			19,717,919				16,811,513
Net income (loss) attributable to common shareholders per share:
Basic		$	(0.04	)		$	(0.05	)
Diluted		$	(0.04	)		$	(0.05	)

Schedule of Reconciliation of shares

		For the Three Months Ended June 30, (Unaudited)
		2022				2021
Numerator:
Net Income (Loss)		$	(862,382	)		$	(778,454	)
Denominator:
Basic weighted-average shares			19,717,919				16,811,513
Effect of dilutive securities
Warrants			-				-
Options			-				-
Preferred Stock			-				-
Diluted Weighted Average Shares			19,717,919				16,811,513
Net Income (Loss) Per Common Share:
Basic		$	(0.04	)		$	(0.05	)
Diluted		$	(0.04	)		$	(0.05	)

		For the Six Months Ended June 30, (Unaudited)
		2022				2021
Numerator:
Net Income (Loss)		$	(1,521,865	)		$	(2,289,394	)
Denominator:
Basic weighted-average shares			19,703,012				16,784,737
Effect of dilutive securities
Warrants			-				-
Options			-				-
Preferred Stock			-				-
Diluted Weighted Average Shares			19,703,012				16,784,737
Net Income (Loss) Per Common Share:
Basic		$	(0.08	)		$	(0.14	)
Diluted		$	(0.08	)		$	(0.14	)

Computation of diluted weighted average shares

		For the Six Months Ended June 30, (Unaudited)
		2022				2021
Net Income (Loss)		$	(1,521,865	)		$	(2,289,394	)
Net income (loss) attributable to common shareholders		$	(1,521,865	)		$	(2,289,394	)
Weighted average number of shares of common stock outstanding:
Basic			19,703,012				16,784,737
Diluted			19,703,012				16,784,737
Net income (loss) attributable to common shareholders per share:
Basic		$	(0.08	)		$	(0.14	)
Diluted		$	(0.08	)		$	(0.14	)

Disaggregation Of Revenue

		For the three months ended June 30, (Unaudited)
		2022				2021
SteraMist Product		$	1,134,000			$	1,026,000
Service and Training			324,000				440,000
Total		$	1,458,000			$	1,466,000

		For the three months ended June 30, (Unaudited)
		2022				2021
United States		$	1,206,000			$	1,184,000
International			252,000				282,000
Total		$	1,458,000			$	1,466,000

		For the six months ended June 30, (Unaudited)
		2022				2021
SteraMist Product		$	3,020,000			$	2,673,000
Service and Training			747,000				866,000
Total		$	3,767,000			$	3,539,000

		For the three months ended June 30, (Unaudited)
		2022				2021
United States		$	2,703,000			$	2,989,000
International			1,064,000				550,000
Total		$	3,767,000			$	3,539,000